Journal of International Medical Research (Mar 2022)

Report of a patient with refractory atrial tachycardia whose heart rate was controlled using ivabradine

  • Lanting Zhao,
  • Rong He,
  • Yuanwei Liu,
  • Fei She,
  • Ying Xie,
  • Ping Zhang

DOI
https://doi.org/10.1177/03000605221081727
Journal volume & issue
Vol. 50

Abstract

Read online

Ivabradine is an effective treatment for focal atrial tachycardia. However, it may also be effective for re-entrant atrial arrhythmia. An 85-year-old woman with a history of underlying ischaemic cardiomyopathy complained of worsening symptoms of heart failure because of rapid atrial tachycardia that was resistant to several rate-controlling drugs, but responded well to ivabradine. An electrophysiology study demonstrated a roof-dependent macro-re-entrant tachycardia of the left atrium. Linear ablation of the left atrial roof resulted in termination of the tachycardia. Thus, ivabradine can be an effective treatment for re-entrant atrial tachycardia.